DMKJ
CDTX

David M. Knott Jr’s Cidara Therapeutics CDTX Stock Holding History

David M. Knott Jr’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34,301
Closed -$431K – 175
2022
Q3 		$431K Buy
34,301
+2,538
+8% +$35K 0.18% 73
2022
Q2 		$310K Buy
31,763
+2,805
+10% +$34.7K 0.13% 80
2022
Q1 		$482K Buy
28,958
+7,513
+35% +$127K 0.15% 78
2021
Q4 		$545K Buy
+21,445
New +$668K 0.19% 69

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David M. Knott Jr's CDTX Position: Q4 2022 in Review

David M. Knott Jr sold out of Cidara Therapeutics (CDTX) in Q4 2022, closing a stake of 34,301 shares — an estimated $431K sold.

David M. Knott Jr first reported a position in CDTX in Q4 2021 and held it in 4 quarters. The position peaked at $545K in Q4 2021. 42 funds tracked by Wall St. Rank hold CDTX as of Q4 2022.

  • David M. Knott Jr reported no remaining Cidara Therapeutics position as of Q4 2022 after selling out during the quarter.
  • David M. Knott Jr sold 34,301 Cidara Therapeutics shares in Q4 2022, an estimated $431K.
  • David M. Knott Jr first reported a position in Cidara Therapeutics in Q4 2021 and held it in 4 quarters.
  • David M. Knott Jr's Cidara Therapeutics position peaked at $545K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2022.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.